Reports
Sale
Global Human Platelet Lysate Market Share, Size, Price, Research: By Type: Heparin-based Human Platelet Lysate, Heparin-free Human Platelet Lysate, Others; By Applications: Research, Therapeutic, Others; By End User; By Distribution Channel; Regional Analysis; Patent Analysis; Grants Analysis; Supplier Landscape; 2024-2032
Global Human Platelet Lysate Market Outlook
The global human platelet lysate market size was valued at USD 52.53 million in 2023. The market is being driven by the rising incidences of various health-related issues and increasing investments in R&D activities of stem cell therapy. The market is anticipated to grow at a CAGR of 3.6% during the forecast period 2024-2032 to reach a value of USD 72.21 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Growing Incidences of Health-Related Issues Augmenting the Market Growth of Human Platelet Lysate
The growth of the human platelet lysate or hPL market is being driven by the growing incidences of chronic autoimmune diseases, haematological and neurological disorders, and cardiovascular and infectious diseases, among others. This, in turn, is increasing the applications of progenitor and stem cell-based therapies, hence surging the demand. With the increasing focus on quality issues regarding purity, traceability, potency, safety, and identity of hPLs, the market is poised to witness lucrative growth opportunities in the coming years.
North America Accounts for a Significant Share of the Market for Human Platelet Lysate
North America holds a significant share of the market, which can be attributed to their extensive utilisation of hPL as a substitute for fetal bovine serum in various applications. Surging investments in research and development (R&D) activities of stem cell therapy by leading companies and governments are bolstering the growth of the market. For instance, in March 2020, the Canadian government announced an investment of about USD 7 million in regenerative medicine and stem cell research.
Meanwhile, Europe is anticipated to be one of the fastest-growing regional markets. This can be associated with the rising use of hPL in manufacturing cell therapeutics due to ethical issues pertaining to animal-derived raw materials in the region.
Market Segmentation
Human platelet lysate or hPL refers to a cell culture supplement that is typically used as an alternative to fetal bovine serum (FBS) for human cell propagation and culture. It is manufactured from intermediate side products of whole blood donations and is rich in growth factors and chemokine molecules. In addition, the product is used to grow mesenchymal stem cells that are derived from diverse species like rabbits and humans, among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on major types, the market is divided into:
- Heparin-based Human Platelet Lysate
- Heparin-free Human Platelet Lysate
- Others
The market can be broadly categorised on the basis of its end uses into:
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Others
By application, the market is segmented into:
- Research
- Therapeutic
The EMR report looks into the regional markets of human platelet lysate like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Interest in Cell-Based Therapies to Fuel the Market Growth of Human Platelet Lysate
The growing interest in cell-based therapies such as mesenchymal stem cell-based therapy is leading to a surge in demand. As growth supplements like foetal bovine serum (FBS) are xenogeneic products and can induce immunologic reactions, hPL is deployed as their alternative.
Advancements in pathogen reduction technologies to boost the safety of hPL are also likely to fuel the market growth. The increasing research and development (R&D) activities to identify the potential of the cell culture growth supplement in the production of clinical-grade cell therapy products are anticipated to provide impetus to market growth.
Due to the growing ethical and animal welfare concerns in the medical and pharmaceutical sectors, hPL is increasingly preferred as it can be produced from outdated platelets. Its surging use for research-grade expansion of endothelial colony-forming progenitor cells is also expected to significantly contribute to the growth of the market. With increasing clinical trials and research activities, the demand for the product in human cell expansion is rising, propelling the growth of the market in the coming years.
Key Players in the Global Human Platelet Lysate Market
The report presents a detailed analysis of the following key players in the global human platelet lysate market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Merck KGaA
- Compass Biomedical, Inc.
- STEMCELL Technologies Inc.
- Sartorius AG
- Life Science Group Ltd
The comprehensive report looks into the macro and micro aspects of the market. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Human Platelet Lysate Market Overview
3.1 Global Human Platelet Lysate Market Historical Value (2017-2023)
3.2 Global Human Platelet Lysate Market Forecast Value (2024-2032)
4 Global Human Platelet Lysate Market Landscape
4.1 Global Human Platelet Lysate Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Human Platelet Lysate Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Human Platelet Lysate Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Human Platelet Lysate Market Segmentation
6.1 Global Human Platelet Lysate Market by Type
6.1.1 Market Overview
6.1.2 Heparin-based Human Platelet Lysate
6.1.3 Heparin-free Human Platelet Lysate
6.1.4 Others
6.2 Global Human Platelet Lysate Market by Applications
6.2.1 Market Overview
6.2.2 Research
6.2.3 Therapeutic
6.2.4 Others
6.3 Global Human Platelet Lysate Market by End User
6.3.1 Market Overview
6.3.2 Pharmaceutical and Biotechnology Companies
6.3.3 Academic and Research Institutes
6.3.4 Others
6.4 Global Human Platelet Lysate Market by Distribution Channel
6.4.1 Market Overview
6.4.2 Online Stores
6.4.3 Retail Stores
6.4.4 Others
6.5 Global Human Platelet Lysate Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Human Platelet Lysate Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Human Platelet Lysate Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Human Platelet Lysate Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Human Platelet Lysate Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Human Platelet Lysate Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Merck KGaA
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Compass Biomedical, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 STEMCELL Technologies Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Sartorius AG
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Life Science Group Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
18 Global Human Platelet Lysate Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The global human platelet lysate market reached a value of USD 52.53 million in 2023.
The market is projected to grow at a CAGR of 3.6% during the forecast period of 2024-2032 to reach a value of USD 72.21 million by 2032.
The market is being aided by the rising incidences of various health-related issues, a growing focus on characterising and defining quality issues of hPLs, and increasing investments in R&D activities of stem cell therapy.
The market is likely to be supported by the rising interest in cell-based therapies, advancements in pathogen reduction technologies, and the growing ethical and animal welfare concerns in the pharmaceutical and medical sectors.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific. North America currently holds a significant market share, while Europe is projected to witness fast growth.
The major types of hPL in the market are heparin-based human platelet lysate and heparin-free human platelet lysate, among others.
The various end uses of hPL are pharmaceutical and biotechnology companies, academic and research institutes, and others.
The significant applications in the market are research and therapeutic.
The major players in the market are Merck KGaA, Compass Biomedical, Inc., STEMCELL Technologies Inc., Sartorius AG, and Life Science Group Ltd.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER